Publications

Export 21427 results:
Sort by: [ Author  (Asc)] Title Type Year
[A] B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
A
Aziz, M. Z., K. ayad, and M. M. Zaki, Maitland versus mulligan mobilization in treatment of knee osteoarthritis, : Cairo university, 2014.
Aziz, A. E., M. Talaat, M. F. El-Asmer, T. Mostafa, S. Mostafa, H. Atta, M. Abdel Aziz Wassef, H. Fouad, L. Rashed, D. Sabry, et al., "ORIGINAL RESEARCH—BASIC SCIENCE: Heme Oxygenase vs. Nitric Oxide Synthase in Signaling Mediating Sildenafil Citrate Action", The journal of sexual medicine, vol. 4, no. 4ii: Blackwell Publishing Inc, pp. 1098–1107, 2007. Abstract
n/a
Aziz, M. S. E. - D. A., M. ElSamahy, M. Moustafa, and F. ElBendary, "A Secure ANFIS based Relay for Turbo-Generators Phase Backup Protection", Indonesian Journal of Electrical Engineering and Computer Science, vol. 3, issue 2, pp. 249-263, 2016. Abstract
n/a
Aziz, T. A., M. A. Aziz, H. H. Fouad, L. A. Rashed, H. Salama, S. Abd-Alla, M. A. A. Wehab, and T. Ahmed, "Interferon-α gene therapy prevents aflatoxin and carbon tetrachloride promoted hepatic carcinogenesis in rats", International journal of molecular medicine, vol. 15, issue 1: Spandidos Publications, pp. 21-26, 2005. Abstract
n/a
Aziz, M. A. M., E. - D. A. E. El-Zahab, A. M. Ibrahim, and A. F. Zobaa, Effect of connecting shunt capacitor on nonlinear load terminals, , vol. 18, issue 4: IEEE, pp. 1450 - 1454, 2003. Abstract
n/a
Aziz, H. S. A., M. A. A. Wassef, M. M. Abdelhalim, A. M. Sayed, and B. S. Saad, "Implementation and Evaluation of Antimicrobial Stewardship Program in Medical ICU in Cairo University Specialized Pediatric Hospital", Open Access Macedonian Journal of Medical Sciences, vol. 8, issue (B), pp. 716-722, 2020.
Aziz, A. A., D. M. A. M. Osman, and S. F. el Shafei, "Assessing speech intelligibility in a group of Egyptian dysarthric patients", Egyptian Journal of Otolaryngology, vol. 27 (2), issue July, pp. 49-55, 2012.
Aziz, D., S. A. Mohamed, S. Tayel, and A. Makhlouf, "Enhanced Ocular Anti-Aspergillus Activity of Tolnaftate Employing Novel Cosolvent-Modified Spanlastics: Formulation, Statistical Optimization, Kill Kinetics, Ex Vivo Trans-Corneal Permeation, In Vivo Histopathological and Susceptibility Study.", Pharmaceutics, vol. 14, issue 8, 2022. Abstract

Tolnaftate (TOL) is a thiocarbamate fungicidal drug used topically in the form of creams and ointments. No ocular formulations of TOL are available for fungal keratitis (FK) treatment due to its poor water solubility and unique ocular barriers. Therefore, this study aimed at developing novel modified spanlastics by modulating spanlastics composition using different glycols for enhancing TOL ocular delivery. To achieve this goal, TOL basic spanlastics were prepared by ethanol injection method using a full 3 factorial design. By applying the desirability function, the optimal formula (BS6) was selected and used as a nucleus for preparing and optimizing TOL-cosolvent spanlastics according to the full 3.2 factorial design. The optimal formula (MS6) was prepared using 30% propylene glycol and showed entrapment efficiency percent (EE%) of 66.10 ± 0.57%, particle size (PS) of 231.20 ± 0.141 nm, and zeta potential (ZP) of -32.15 ± 0.07 mV. MS6 was compared to BS6 and both nanovesicles significantly increased the corneal permeation potential of TOL than drug suspension. Additionally, in vivo histopathological experiment was accomplished and confirmed the tolerability of MS6 for ocular use. The fungal susceptibility testing using confirmed that MS6 displayed more durable growth inhibition than drug suspension. Therefore, MS6 can be a promising option for enhanced TOL ocular delivery.

Aziz, A. S. A., A. T. Azar, A. E. Hassanien, and S. E. - O. Hanafy, "Continuous features discretization for anomaly intrusion detectors generation", Soft computing in industrial applications: Springer International Publishing, pp. 209–221, 2014. Abstract
n/a
Aziz, A. N. Y., S. Mogawer, U. M. A. Garhi, M. A. Ansary, M. Rakha, and H. el shemy, "IMPROVEMENT IN FATIGUE STATUS IN PATIENTS WITH LIVER CIRRHOSIS DUE TO CHRONIC VIRAL HEPATITIS C AFTER VITAMIN D SUPPLEMENTATION", Acta Medica Mediterranea , 2021.
Aziz, M. T., M. F. El-Asmar, T. Mostafa, H. Atta, M. A. Wassef, H. Fouad, N. K. Roshdy, L. Rashed, and D. Sabry, "Effects of NOS and HO inducers and inhibitors on molecular signaling of erectile function", J Clin Biochem Nutr , vol. 37, issue 3, pp. 103-111., 2005.
Aziz, M. T. A., M. F. El-Asmar, T. Mostafa, H. Atta, M. A. A. Wassef, H. H. Fouad, N. K. Roshdy, L. A. Rashed, and D. Sabry, "Effects of nitric oxide synthase and heme oxygenase inducers and inhibitors on molecular signaling of erectile function", Journal of Clinical Biochemistry and Nutrition, vol. 37, issue 3: 日本酸化ストレス学会 JCBN 事務局, pp. 103-111, 2005. Abstract
n/a
Aziz, R. K., J. M. Monk, K. A. Andrews, J. Nhan, V. L. Khaw, H. Wong, B. O. Palsson, and P. Charusanti, "The aldehyde dehydrogenase, AldA, is essential for L-1,2-propanediol utilization in laboratory-evolved Escherichia coli.", Microbiological research, vol. 194, pp. 47-52, 2017 Jan. Abstract

Most Escherichia coli strains are naturally unable to grow on 1,2-propanediol (PDO) as a sole carbon source. Recently, however, a K-12 descendent E. coli strain was evolved to grow on 1,2-PDO, and it was hypothesized that this evolved ability was dependent on the aldehyde dehydrogenase, AldA, which is highly conserved among members of the family Enterobacteriacea. To test this hypothesis, we first performed computational model simulation, which confirmed the essentiality of the aldA gene for 1,2-PDO utilization by the evolved PDO-degrading E. coli. Next, we deleted the aldA gene from the evolved strain, and this deletion was sufficient to abolish the evolved phenotype. On re-introducing the gene on a plasmid, the evolved phenotype was restored. These findings provide experimental evidence for the computationally predicted role of AldA in 1,2-PDO utilization, and represent a good example of E. coli robustness, demonstrated by the bacterial deployment of a generalist enzyme (here AldA) in multiple pathways to survive carbon starvation and to grow on a non-native substrate when no native carbon source is available.

Aziz, A. M. T., A. E. H. M. c E.A. Abd El Nabi a, b, R. L. A. d D. Sabry a, H.M. Atta a, and A. Shamaa, "Endothelial Progenitor Cells and Development of Collateral Formation in Patients with Chronic Total Coronary Artery Occlusion and Transplantation of Epcs in an Experimental Model . ", EuroPCR and the European 2012 conference, Association of Percutaneous Cadiovascular Interventions (EAPCI) 2012 conference, 2012.
Aziz, M. A. A., M. A. Shawky, and M. Atef, "Oral Squamous Cell Carcinoma Associated with Papillon-Lefevre Syndrome: Systematic Review and the First Reported Case ", International Journal of Dental Medicine, vol. 4, pp. 31-35, 2018.
Aziz, A. A. B., E.S.Hegazi, T. A. Yehia, N. E. Kassim, and T. S. M. Mahmoud, "Growth, Flowering and Fruiting of Manzanillo Olive Trees as Affected by Benzyladenine", Journal of Horticultural Science & Ornamental Plants, vol. 3, issue 3, pp. 244-251., 2011.
Aziz, A. E., M. Talaat, E. Asmer, M. Farid, T. Mostafa, H. Atta, S. Mahfouz, H. Fouad, L. Rashed, D. Sabry, et al., "Effects of losartan, HO-1 inducers or HO-1 inhibitors on erectile signaling in diabetic rats", The journal of sexual medicine, vol. 6, no. 12: Wiley Online Library, pp. 3254–3264, 2009. Abstract
n/a
Aziz, N. A., J. K. Nono, T. Mpotje, and F. Brombacher, "The Foxp3+ regulatory T-cell population requires IL-4Rα signaling to control inflammation during helminth infections.", PLoS biology, vol. 16, issue 10, pp. e2005850, 2018 Oct. Abstract

Forkhead box P3 (Foxp3+) regulatory T (Treg)-cell function is controlled by environmental cues of which cytokine-mediated signaling is a dominant component. In vivo, interleukin-4 (IL-4)-mediated signaling via IL-4 receptor alpha (IL-4Rα) mediates Treg cell transdifferentiation into ex-Foxp3 T helper 2 (Th2) or T helper 17 (Th17) cells. However, IL-4-mediated signaling also reinforces the Foxp3 Treg compartment in vitro. We generated Foxp3-specific IL-4Rα-deficient mice and demonstrated differential efficiency of IL-4Rα deletion in male (approximately 90%) and female (approximately 40%) animals, because of cyclic recombinase (Cre)-mediated X-linked foxp3 inactivation. Irrespective of the degree of IL-4Rα deletion within the Foxp3+ Treg cell population, mice showed exacerbation of immune effector responses with aggravated tissue pathology in tissue-dwelling helminth infections (Schistosoma mansoni or Nippostrongylus brasiliensis). Mechanistically, IL-4Rα deletion in males and females led to a reduced expression of Foxp3 and subsequently an impaired accumulation of Foxp3+ Treg cells to inflamed tissues. In-depth cellular typing by flow cytometry revealed that the impairment of IL-4Rα-mediated signaling during helminth infections decreased the ability of central Treg cells to convert into effector Treg (eTreg) cells and caused a significant down-regulation of markers associated with Treg cell migration (C-X-C motif chemokine receptor 3 [CXCR3]) and accumulation in inflamed tissues (GATA binding protein 3 [GATA3]) as well as survival (B cell lymphoma 2 [Bcl-2]). These findings unprecedentedly, to our knowledge, uncover a role for IL-4Rα signaling in the positive regulation of Foxp3+ Treg cell function in vivo. Complementing our past knowledge on a widely reported role for IL-4Rα signaling in the negative regulation and transdifferentiation of Foxp3+ Treg cells in vivo, our present findings reveal the host requirement for an intact, but not reduced or potentiated, IL-4Rα-mediated signaling on Foxp3+ Treg cells to optimally control inflammation during helminth infections.

Aziz, M. A. - E., "The Mixolab Parameters of Wheat/Quinoa Composite Flour and Their Relation to Quality Characteristics", Egyptian Journal of Nutrition, vol. 34, issue 2, pp. 89-112, 2019.
Aziz, H. A., H. Omar, M. Khalil, A. Cordie, R. Mohamed, M. Abdallah, M. H. Abdel Maksoud, N. El Garhy, L. Ali, M. E. Serafy, et al., "Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience.", Expert review of anti-infective therapy, vol. 20, issue 5, pp. 789-795, 2022. Abstract

BACKGROUND: Liver disease has emerged as a leading cause of death among PLHIV coinfected with HCV.

METHODS: A retrospective study involving all HCV viremic patients coinfected with HIV who presented to HCV/HIV multidisciplinary clinics located at Embaba fever hospital. Patients were assigned to receive DAAs according to the national treatment guidelines. The primary endpoint was SVR12.

RESULTS: Of the 519 patients enrolled, 38.73% LTFU; either not initiated (n = 170) or did not complete the treatment (n = 31). The main identified reasons behind LTFU were schedule conflict (19%) or hospitalization (13%). Among 318 patients who completed their DAAs course, nine patients had a relapse after the end of treatment and 97% had attained SVR12. There were significant differences among different virological response groups in baseline factors including smoking (p = 0.005), history of dental procedure (p = 0.007), CD4 count (p = 0.007), and HIV viral load (p = <0.001). Among responders (n = 309), there was a significant reduction of baseline hemoglobin and significant improvement of baseline platelets (p = 0.005) at on-treatment week 8. Baseline necro-inflammatory markers showed significant improvement across follow-up time points (p < 0.001).

CONCLUSIONS: DAAs are an effective and safe choice to treat HCV in PLHIV. Social stigma could be a major cause for lacking adherence to follow-up visits. ALT: Alanine Aminotransferase; ARV: Antiretroviral treatment; AST: Aspartate Aminotransferase; DAAs: Direct acting antivirals; ARVs: antiretroviral therapy; EMR: Eastern Mediterranean region; HCV: Hepatitis C virus; kPa: Kilopascal; LTFU: Patient lost to follow up; NCCVH: The National Committee for Control of Viral Hepatitis; PWID: People who inject drugs; SVR: Sustained virological response;UNAIDS: The Joint United Nations Programme on HIV/AIDS.

m. Aziz, A. T., D. El-Miligy, M. Amin, E. A. Ansari, H. A. Hosny, S. A. Marzouk, and D. Sabry, "Molecular evaluation of apoptotic versus antiapoptotic angiogenic markers in hepatocellular carcinoma", Clinical Biochemistry, vol. 41, issue 12, pp. 1008–1014, 2008. molecular_evaluation_of_apoptotic_versus_antiapoptotic_angiogenic_markers_in_hepatocellular_carcinoma.pdf
Aziz, M. S. A., M. A. M. Hassan, and E. A. Zahab, "High-impedance Faults Analysis in Distribution Networks Using an Adaptive Neuro Fuzzy Inference System", Electric Power Components and Systems, vol. 40, no. 11: Taylor & Francis, pp. 1300–1318, 2012. Abstract
n/a
Aziz, T. A., M. A. Aziz, H. H. Fouad, L. A. Rashed, H. Salama, S. Abd-Alla, M. A. A. Wehab, and T. Ahmed, "Interferon-$\alpha$ gene therapy prevents aflatoxin and carbon tetrachloride promoted hepatic carcinogenesis in rats", International journal of molecular medicine, vol. 15, no. 1: Spandidos Publications, pp. 21–26, 2005. Abstract
n/a
Aziz, M. T. A., M. F. El-Asmar, A. M. Rezq, M. A. A. Wassef, H. Fouad, N. K. Roshdy, H. H. Ahmed, L. A. Rashed, D. Sabry, F. M. Taha, et al., "Effects of a novel curcumin derivative on insulin synthesis and secretion in streptozotocin-treated rat pancreatic islets in vitro", Chinese medicine, vol. 9, no. 1: BioMed Central, pp. 1–12, 2014. Abstract
n/a
Aziz, R. K., "Interview with Prof. Ramy K. Aziz, Cairo University. The Dawn of Pharmacomicrobiomics", OMICS: A Journal of Integrative Biology, vol. 22, no. 4: Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA, pp. 295–297, 2018. Abstract
n/a
Tourism